Is a complete LUNG research report available?

No complete published report is available for Pulmonx Corporation (LUNG) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Pulmonx Corporation (LUNG)

NASDAQ: LUNG · USD

$2.85

+0.13 (+4.6%)· Recorded snapshot

Market cap	122.2M
Revenue (ttm)	88.8M
Net income (ttm)	-42.6M
EPS (ttm)	-$1.01
Shares out	42.9M
Volume	885,136
Beta	0.34

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 88.8M
Net income (ttm): -42.6M
EPS (ttm): -$1.01
Market cap: 122.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	보유

Metric	Value
Amount currency	USD
CIK code	0001127537
Company name	Pulmonx Corporation
Country	United States
Country code	US
CUSIP number	745848101
Earnings date	2026-10-27
Earnings time	amc
Employees	296
Employees change	5
Employees growth	1.72%
Enterprise value	$125.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-09
Fiscal year end	December
Founded	1995
Industry	Medical Devices
IPO date	2020-10-01
Is primary listing	Yes
Is SPAC	No
ISIN number	US7458481014
Last 10-K release date	2026-03-10
Last earnings date	2026-10-27
Last refreshed	2026-11-04
Last stock split type	Never
Market cap	$122.2M
Market cap category	Micro-Cap
Next earnings date	2027-03-03
Options	Yes
Price	$2.85
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-11-04
Symbol	LUNG
U.S. state	California
Website	https://www.pulmonx.com

Metric

Value

Amount currency

USD

CIK code

0001127537

Company name

Pulmonx Corporation

Country

United States

Country code

CUSIP number

745848101

Earnings date

2026-10-27

Earnings time

amc

Employees

296

Employees change

Employees growth

1.72%

Enterprise value

$125.8M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-09-30

First seen

2026-05-09

Fiscal year end

December

Founded

1995

Industry

Medical Devices

IPO date

2020-10-01

Is primary listing

Yes

Is SPAC

ISIN number

US7458481014

Last 10-K release date

2026-03-10

Last earnings date

2026-10-27

Last refreshed

2026-11-04

Last stock split type

Never

Market cap

$122.2M

Market cap category

Micro-Cap

Next earnings date

2027-03-03

Options

Yes

Price

$2.85

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-11-04

Symbol

LUNG

U.S. state

California

Website

https://www.pulmonx.com

Metric	Value
Earnings yield	-35.41%
EV/Sales	1.41x
FCF / EV yield	-24.58%
FCF yield	-25.32%
Forward EV/Sales	1.29x
Forward P/S	1.25x
Industry forward P/E	20.29x
Industry P/E	41.22x
P/B ratio	3.43x
P/S ratio	1.36x
Price / tangible book value	3.8x
Sector forward P/E	23.32x
Sector P/E	49.47x

Metric

Value

Earnings yield

-35.41%

EV/Sales

1.41x

FCF / EV yield

-24.58%

FCF yield

-25.32%

Forward EV/Sales

1.29x

Forward P/S

1.25x

Industry forward P/E

20.29x

Industry P/E

41.22x

P/B ratio

3.43x

P/S ratio

1.36x

Price / tangible book value

3.8x

Sector forward P/E

23.32x

Sector P/E

49.47x

Metric	Value
EBIT margin	-44.39%
EBITDA margin	-43.27%
Gross margin	77.42%
Operating margin	-44.39%
Pretax margin	-47.24%
Profit margin	-47.93%
Profit per employee	$-143,760
Revenue per employee	$299,916
ROA	-19.82%
ROA (5Y)	-18.66%
ROCE	-44.04%
ROE	-90.31%
ROE (5Y)	-46.85%
ROIC	-23.78%
SBC / revenue	19.72%
Tax / revenue	0.7%

Metric

Value

EBIT margin

-44.39%

EBITDA margin

-43.27%

Gross margin

77.42%

Operating margin

-44.39%

Pretax margin

-47.24%

Profit margin

-47.93%

Profit per employee

$-143,760

Revenue per employee

$299,916

ROA

-19.82%

ROA (5Y)

-18.66%

ROCE

-44.04%

ROE

-90.31%

ROE (5Y)

-46.85%

ROIC

-23.78%

SBC / revenue

19.72%

Tax / revenue

0.7%

Metric	Value
EPS growth quarters	5
EPS growth years	2
Gross profit growth	2.29%
Gross profit growth (Q)	8.39%
Gross profit growth 3Y	13.07%
Gross profit growth 5Y	16.19%
Net income growth quarters	5
Net income growth years	2
Revenue growth	-3.15%
Revenue growth (Q)	6.2%
Revenue growth (QoQ)	0.35%
Revenue growth 3Y	11.05%
Revenue growth 5Y	14.79%
Revenue growth years	7

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

2.29%

Gross profit growth (Q)

8.39%

Gross profit growth 3Y

13.07%

Gross profit growth 5Y

16.19%

Net income growth quarters

Net income growth years

Revenue growth

-3.15%

Revenue growth (Q)

6.2%

Revenue growth (QoQ)

0.35%

Revenue growth 3Y

11.05%

Revenue growth 5Y

14.79%

Revenue growth years

Metric	Value
Capital expenditures	$-112,000
Depreciation and amortization	$997,000
EBIT	$-39.4M
EBITDA	$-38.4M
EPS	$-1.01
FCF per share	$-0.71
Financing cash flow	$1.7M
Free cash flow	$-30.7M
Free cash flow minus SBC	$-47.9M
Gross profit	$68.7M
Income taxes	$619,000
Investing cash flow	$8.7M
Net borrowing	$1.7M
Net cash flow	$-19.6M
Net income	$-42.6M
Operating cash flow minus SBC	$-47.8M
Operating income	$-39.4M
Revenue	$88.8M
Stock-based compensation	$17.2M

Metric

Value

Capital expenditures

$-112,000

Depreciation and amortization

$997,000

EBIT

$-39.4M

EBITDA

$-38.4M

EPS

$-1.01

FCF per share

$-0.71

Financing cash flow

$1.7M

Free cash flow

$-30.7M

Free cash flow minus SBC

$-47.9M

Gross profit

$68.7M

Income taxes

$619,000

Investing cash flow

$8.7M

Net borrowing

$1.7M

Net cash flow

$-19.6M

Net income

$-42.6M

Operating cash flow minus SBC

$-47.8M

Operating income

$-39.4M

Revenue

$88.8M

Stock-based compensation

$17.2M

Metric	Value
Altman Z-Score	-6.16
Book value per share	$0.79
Debt / equity	1.65
Goodwill	$2.3M
Interest coverage	-9.39
Long-term assets	$26.2M
Long-term liabilities	$55.3M
Net cash (debt)	$-3.7M
Net cash / market cap	-3.02%
Net debt / equity	0.11
Piotroski F-Score	3
Property, plant and equipment	$18.8M
Shareholders' equity	$34.2M
Tangible book value	$31.9M
Tangible book value per share	$0.74
Total assets	$110.2M
Total cash	$52.7M
Total debt	$56.3M
Total liabilities	$76M
WACC	6.03%

Metric

Value

Altman Z-Score

-6.16

Book value per share

$0.79

Debt / equity

1.65

Goodwill

$2.3M

Interest coverage

-9.39

Long-term assets

$26.2M

Long-term liabilities

$55.3M

Net cash (debt)

$-3.7M

Net cash / market cap

-3.02%

Net debt / equity

0.11

Piotroski F-Score

Property, plant and equipment

$18.8M

Shareholders' equity

$34.2M

Tangible book value

$31.9M

Tangible book value per share

$0.74

Total assets

$110.2M

Total cash

$52.7M

Total debt

$56.3M

Total liabilities

$76M

WACC

6.03%

Metric	Value
Asset turnover	0.71
Current assets	$84.1M
Current liabilities	$20.7M
Current ratio	4.05
Inventory turnover	1.27
Net working capital	$12.1M
Quick ratio	3.12
Working capital	$63.3M
Working capital turnover	1.17

Metric

Value

Asset turnover

0.71

Current assets

$84.1M

Current liabilities

$20.7M

Current ratio

4.05

Inventory turnover

1.27

Net working capital

$12.1M

Quick ratio

3.12

Working capital

$63.3M

Working capital turnover

1.17

Metric	Value
Buyback yield / dilution	-5%
Dividend yield	0%
Shareholder yield	-5%

Metric

Value

Buyback yield / dilution

-5%

Dividend yield

Shareholder yield

-5%

Metric	Value
150-day SMA	$1.71
1D price change	4.6%
1M price change	54.65%
1M total return	54.65%
1W price change	12.3%
1W total return	12.3%
1Y price change	54.65%
1Y return CAGR	54.69%
1Y total return	54.65%
20-day SMA	$2.12
200-day SMA	$1.67
3M price change	33.49%
3M total return	33.49%
3Y price change	-71.47%
3Y return CAGR	-34.16%
3Y total return	-71.47%
50-day SMA	$2.08
50-day SMA vs 200-day SMA	50over200
52-week high	$3.25
52-week high date	2026-10-29
52-week low	$1.13
52-week low date	2026-03-30
5Y price change	-93.4%
5Y return CAGR	-41.94%
5Y total return	-93.4%
6M price change	109.63%
6M total return	109.63%
After-hours change	-0.74%
After-hours close	$2.72
After-hours price	$2.70
All-time high	$69.48
All-time high date	2020-12-31
All-time low	$1.13
All-time low date	2026-03-30
Average true range (ATR)	$0.25
Average volume	1.1M
Beta (1Y)	2.71
Beta (2Y)	1.44
Beta (5Y)	0.34
Change from 52-week high	-12.46%
Change from 52-week low	151.77%
Change from all-time high	-95.93%
Change from all-time low	150.44%
Change from open	1.61%
Day's gap	2.94%
Dollar volume	$2.5M
High price	$3.02
Low price	$2.77
Monthly RSI	43.85
Open price	$2.80
Position in 52-week range	31.37%
Premarket change	1.1%
Premarket close	$2.72
Premarket price	$2.75
Premarket volume	5.3K
Previous close	$2.72
Price vs 150-day SMA	65.59%
Price vs 20-day SMA	33.24%
Price vs 200-day SMA	69.46%
Price vs 50-day SMA	36.39%
Relative volume	0.78
Return from IPO open	-92.95%
Return from IPO price	-85.16%
RSI	65.92
Sharpe ratio	0.87
Sharpe ratio (3Y)	-0
Sharpe ratio (5Y)	-0.2
Sortino ratio	1.67
Sortino ratio (3Y)	0.07
Sortino ratio (5Y)	-0.22
Volume	885.1K
Weekly RSI	63.62
YTD price change	28.05%
YTD total return	28.05%

Metric

Value

150-day SMA

$1.71

1D price change

4.6%

1M price change

54.65%

1M total return

54.65%

1W price change

12.3%

1W total return

12.3%

1Y price change

54.65%

1Y return CAGR

54.69%

1Y total return

54.65%

20-day SMA

$2.12

200-day SMA

$1.67

3M price change

33.49%

3M total return

33.49%

3Y price change

-71.47%

3Y return CAGR

-34.16%

3Y total return

-71.47%

50-day SMA

$2.08

50-day SMA vs 200-day SMA

50over200

52-week high

$3.25

52-week high date

2026-10-29

52-week low

$1.13

52-week low date

2026-03-30

5Y price change

-93.4%

5Y return CAGR

-41.94%

5Y total return

-93.4%

6M price change

109.63%

6M total return

109.63%

After-hours change

-0.74%

After-hours close

$2.72

After-hours price

$2.70

All-time high

$69.48

All-time high date

2020-12-31

All-time low

$1.13

All-time low date

2026-03-30

Average true range (ATR)

$0.25

Average volume

1.1M

Beta (1Y)

2.71

Beta (2Y)

1.44

Beta (5Y)

0.34

Change from 52-week high

-12.46%

Change from 52-week low

151.77%

Change from all-time high

-95.93%

Change from all-time low

150.44%

Change from open

1.61%

Day's gap

2.94%

Dollar volume

$2.5M

High price

$3.02

Low price

$2.77

Monthly RSI

43.85

Open price

$2.80

Position in 52-week range

31.37%

Premarket change

1.1%

Premarket close

$2.72

Premarket price

$2.75

Premarket volume

5.3K

Previous close

$2.72

Price vs 150-day SMA

65.59%

Price vs 20-day SMA

33.24%

Price vs 200-day SMA

69.46%

Price vs 50-day SMA

36.39%

Relative volume

0.78

Return from IPO open

-92.95%

Return from IPO price

-85.16%

RSI

65.92

Sharpe ratio

0.87

Sharpe ratio (3Y)

-0

Sharpe ratio (5Y)

-0.2

Sortino ratio

1.67

Sortino ratio (3Y)

0.07

Sortino ratio (5Y)

-0.22

Volume

885.1K

Weekly RSI

63.62

YTD price change

28.05%

YTD total return

28.05%

Metric	Value
Float	37.6M
Float percentage	87.57%
Shares change (QoQ)	1.67%
Shares change (YoY)	5%
Shares held by insiders	5.94%
Shares held by institutions	54.74%
Shares outstanding	42.9M
Short % of float	1.86%
Short % of shares	1.63%
Short ratio	2.6 days

Metric

Value

Float

37.6M

Float percentage

87.57%

Shares change (QoQ)

1.67%

Shares change (YoY)

Shares held by insiders

5.94%

Shares held by institutions

54.74%

Shares outstanding

42.9M

Short % of float

1.86%

Short % of shares

1.63%

Short ratio

2.6 days

Pulmonx Corporation (LUNG)

Price

Financial snapshot

Fair-value bridge

Latest news · LUNG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LUNG indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LUNG

Frequently asked questions